文献速递区域麻醉与超声术前评估与围术期医学

神经周围低剂量地塞米松较全身用药延长肌间沟阻滞镇痛

Perineural Low-Dose Dexamethasone Prolongs Interscalene Block Analgesia With Bupivacaine Compared With Systemic Dexamethasone: A Randomized Trial.
PubMed 文献 · Reg Anesth Pain Med · 2018-01-01

这项三盲随机试验比较1 mg神经周围与静脉地塞米松对肌间沟阻滞镇痛时长的影响。接受门诊肩关节镜的患者使用0.5%布比卡因15 mL联合地塞米松。神经周围组镇痛完全消退的中位时间比静脉组延长3.5小时(95%CI 1.0-6.0,P=0.007),但未达预设5小时最小临床意义差值。

要点

  • 1 mg神经周围地塞米松较1 mg静脉用药延长肌间沟阻滞镇痛完全消退中位时间3.5小时。
  • 镇痛开始消退时间神经周围组亦延长5.5小时(95%CI 2.1-9.0,P=0.002)。
  • 阿片消耗、满意度及疼痛评分两组无差异。

核心结论

  • 在肩关节镜患者中,1 mg神经周围地塞米松联合0.5%布比卡因15 mL较1 mg静脉地塞米松延长肌间沟阻滞镇痛完全消退的中位时间,但延长幅度小于预设5小时最小临床意义差值。

研究设计与样本

  • 三盲随机试验,比较神经周围与静脉1 mg地塞米松;神经周围组63例、静脉组62例完成主要结局随访。

主要发现

  • 肌间沟阻滞镇痛完全消退的中位时间神经周围组比静脉组延长3.5小时(95%CI 1.0-6.0,P=0.007)。
  • 镇痛开始消退的时间神经周围组比静脉组延长5.5小时(95%CI 2.1-9.0,P=0.002)。
  • 阿片消耗、满意度及疼痛评分等次要结局两组无差异。

关键数值与推荐

  • 神经周围组与静脉组均使用0.5%布比卡因15 mL及无防腐剂地塞米松1 mg。
  • 所有患者接受静脉酮咯酸,出院带萘普生500 mg每日两次及按需羟考酮/对乙酰氨基酚。
  • 预设最小临床意义差值为5小时。

临床怎么用

  • 对接受门诊肩关节镜肌间沟阻滞的患者,可考虑神经周围给予1 mg地塞米松以适度延长镇痛,但需知晓延长幅度有限且未达最小临床意义差值。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Perineural dexamethasone and intravenous (IV) dexamethasone have been shown to prolong peripheral nerve block duration. The effects of perineural and IV dexamethasone have only been compared at doses of 4 mg or greater. This triple-blind, randomized trial examined the effect of 1 mg IV versus perineural dexamethasone on interscalene block (ISB) analgesia duration. METHODS: Patients undergoing ambulatory shoulder arthroscopy received an ultrasound-guided ISB with 15 mL bupivacaine 0.5% and 1 mg preservative-free dexamethasone that was administered perineurally (PeriD) or IV (IVDex). All patients received IV ketorolac and were discharged on naproxen 500 mg 2 times a day plus oxycodone/acetaminophen as needed. Peripheral nerve block duration, pain, opioid consumption, and block satisfaction were assessed via telephone follow-ups. RESULTS: There were 63 PeriD patients and 62 IVDex patients who completed the primary outcome follow-up. The median time until analgesia from the ISB completely wore off was 3.5 hours (95% confidence interval, 1.0-6.0 hours) longer in the PeriD versus IVDex groups; P = 0.007). Time until the pain relief from the ISB began to wear off was also longer in the PeriD versus IVDex group (5.5 hours [95% confidence interval, 2.1-9.0 hours]; P = 0.002). Other secondary outcomes, including opioid consumption, satisfaction, and pain scores, were not different between groups. CONCLUSIONS: In patients undergoing shoulder arthroscopy, low-dose perineural dexamethasone (1 mg) in combination with 15 mL of 0.5% bupivacaine prolonged the median time until pain relief from the ISB completely wore off compared with 1 mg IV dexamethasone. However, the degree of prolongation was smaller than the a priori-defined minimal clinically meaningful difference of 5 hours. CLINICAL TRIAL REGISTRATION: This study was registered at Clinicaltrials.gov, identifier NCT02506660.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Kahn RL, Cheng J, Gadulov Y, et al. Perineural Low-Dose Dexamethasone Prolongs Interscalene Block Analgesia With Bupivacaine Compared With Systemic Dexamethasone: A Randomized Trial. Reg Anesth Pain Med. 2018. PMID: 29889698. doi:10.1097/AAP.0000000000000817

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。